• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYLD在非黑色素瘤皮肤癌中的肿瘤抑制功能

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

作者信息

Masoumi K C, Shaw-Hallgren Gina, Massoumi Ramin

机构信息

Molecular Tumor Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, 205 02 Malmö, Sweden.

出版信息

J Skin Cancer. 2011;2011:614097. doi: 10.1155/2011/614097. Epub 2011 Dec 17.

DOI:10.1155/2011/614097
PMID:22235375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3246786/
Abstract

Ubiquitin and ubiquitin-related proteins posttranslationally modify substrates, and thereby alter the functions of their targets. The ubiquitination process is involved in various physiological responses, and dysregulation of components of the ubiquitin system has been linked to many diseases including skin cancer. The ubiquitin pathways activated among skin cancers are highly diverse and may reflect the various characteristics of the cancer type. Basal cell carcinoma and squamous cell carcinoma, the most common types of human skin cancer, are instances where the involvement of the deubiquitination enzyme CYLD has been recently highlighted. In basal cell carcinoma, the tumor suppressor protein CYLD is repressed at the transcriptional levels through hedgehog signaling pathway. Downregulation of CYLD in basal cell carcinoma was also shown to interfere with TrkC expression and signaling, thereby promoting cancer progression. By contrast, the level of CYLD is unchanged in squamous cell carcinoma, instead, catalytic inactivation of CYLD in the skin has been linked to the development of squamous cell carcinoma. This paper will focus on the current knowledge that links CYLD to nonmelanoma skin cancers and will explore recent insights regarding CYLD regulation of NF-κB and hedgehog signaling during the development and progression of these types of human tumors.

摘要

泛素及泛素相关蛋白可对底物进行翻译后修饰,从而改变其靶标的功能。泛素化过程参与多种生理反应,泛素系统各组分的失调与包括皮肤癌在内的多种疾病相关。皮肤癌中激活的泛素途径高度多样,可能反映了癌症类型的各种特征。基底细胞癌和鳞状细胞癌是人类最常见的皮肤癌类型,最近有研究突出显示了去泛素化酶CYLD在其中的作用。在基底细胞癌中,肿瘤抑制蛋白CYLD通过刺猬信号通路在转录水平受到抑制。基底细胞癌中CYLD的下调还被证明会干扰TrkC的表达和信号传导,从而促进癌症进展。相比之下,CYLD的水平在鳞状细胞癌中没有变化,相反,皮肤中CYLD的催化失活与鳞状细胞癌的发生有关。本文将聚焦于目前将CYLD与非黑色素瘤皮肤癌联系起来的知识,并探讨关于CYLD在这些类型的人类肿瘤发生和进展过程中对NF-κB和刺猬信号通路调控的最新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/738faef0636e/JSC2011-614097.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/754836e20e2c/JSC2011-614097.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/2ab98b61e416/JSC2011-614097.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/81fb97fd566e/JSC2011-614097.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/738faef0636e/JSC2011-614097.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/754836e20e2c/JSC2011-614097.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/2ab98b61e416/JSC2011-614097.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/81fb97fd566e/JSC2011-614097.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e79/3246786/738faef0636e/JSC2011-614097.004.jpg

相似文献

1
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.CYLD在非黑色素瘤皮肤癌中的肿瘤抑制功能
J Skin Cancer. 2011;2011:614097. doi: 10.1155/2011/614097. Epub 2011 Dec 17.
2
CYLD: a deubiquitination enzyme with multiple roles in cancer.CYLD:一种具有多种癌症相关作用的去泛素化酶。
Future Oncol. 2011 Feb;7(2):285-97. doi: 10.2217/fon.10.187.
3
The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.E3 泛素连接酶 MIB2 通过降解去泛素化酶 CYLD 增强炎症反应。
J Biol Chem. 2019 Sep 20;294(38):14135-14148. doi: 10.1074/jbc.RA119.010119. Epub 2019 Jul 31.
4
CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.CYLD:一种肿瘤抑制去泛素化酶,调节 NF-κB 激活和多种生物过程。
Cell Death Differ. 2010 Jan;17(1):25-34. doi: 10.1038/cdd.2009.43.
5
Ubiquitin chain cleavage: CYLD at work.泛素链裂解:CYLD 在工作。
Trends Biochem Sci. 2010 Jul;35(7):392-9. doi: 10.1016/j.tibs.2010.02.007. Epub 2010 Mar 26.
6
CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.CYLD 通过在多个层面阻断 JNK/AP1 信号通路来抑制肿瘤发生和转移。
Cancer Prev Res (Phila). 2011 Jun;4(6):851-9. doi: 10.1158/1940-6207.CAPR-10-0360. Epub 2011 Apr 8.
7
GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.基底细胞癌中 GLi1 依赖性的 CYLD 转录抑制。
Oncogene. 2011 Nov 3;30(44):4523-30. doi: 10.1038/onc.2011.163. Epub 2011 May 16.
8
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.CYLD 通过 JNK 依赖的信号通路控制肝癌细胞中的 c-MYC 表达。
Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8.
9
CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.CYLD是一种去泛素化酶,通过肿瘤坏死因子受体(TNFR)家族成员对核因子κB(NF-κB)的激活起负向调节作用。
Nature. 2003 Aug 14;424(6950):793-6. doi: 10.1038/nature01803.
10
Clinical significance of CYLD downregulation in breast cancer.CYLD 下调在乳腺癌中的临床意义。
Breast Cancer Res Treat. 2014 Feb;143(3):447-57. doi: 10.1007/s10549-013-2824-3. Epub 2014 Jan 8.

引用本文的文献

1
A computational approach for structural and functional analyses of disease-associated mutations in the human CYLD gene.一种用于人类CYLD基因疾病相关突变的结构和功能分析的计算方法。
Genomics Inform. 2024 May 31;22(1):4. doi: 10.1186/s44342-024-00007-2.
2
Genetic Testing in CYLD Cutaneous Syndrome: An Update.CYLD皮肤综合征的基因检测:最新进展
Appl Clin Genet. 2021 Oct 29;14:427-444. doi: 10.2147/TACG.S288274. eCollection 2021.
3
CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice.CYLD 抑制免疫活性小鼠皮肤鳞状细胞肿瘤的发展。

本文引用的文献

1
GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.基底细胞癌中 GLi1 依赖性的 CYLD 转录抑制。
Oncogene. 2011 Nov 3;30(44):4523-30. doi: 10.1038/onc.2011.163. Epub 2011 May 16.
2
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.TRK 信号通路失调是 CYLD 缺陷型肿瘤的治疗靶点。
Oncogene. 2011 Oct 13;30(41):4243-60. doi: 10.1038/onc.2011.133. Epub 2011 May 9.
3
CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.CYLD 通过在多个层面阻断 JNK/AP1 信号通路来抑制肿瘤发生和转移。
Int J Mol Sci. 2021 Jun 23;22(13):6736. doi: 10.3390/ijms22136736.
4
CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.CYLD 改变与人类乳头瘤病毒相关的头颈部癌症的肿瘤发生和进展。
Mol Cancer Res. 2021 Jan;19(1):14-24. doi: 10.1158/1541-7786.MCR-20-0565. Epub 2020 Sep 3.
5
A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family.一个新的 CYLD 基因大片段缺失导致一个中国家族患 CYLD 皮肤综合征。
Mol Genet Genomic Med. 2020 Oct;8(10):e1441. doi: 10.1002/mgg3.1441. Epub 2020 Aug 11.
6
miR-454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD.微小RNA-454通过靶向CYLD促进胃癌细胞存活并诱导奥沙利铂耐药。
Exp Ther Med. 2020 Jun;19(6):3604-3610. doi: 10.3892/etm.2020.8655. Epub 2020 Apr 9.
7
Premature aging and cancer development in transgenic mice lacking functional CYLD.缺乏功能性CYLD的转基因小鼠的早衰和癌症发展。
Aging (Albany NY). 2019 Jan 10;11(1):127-159. doi: 10.18632/aging.101732.
8
A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib.一例多发性家族性毛发上皮瘤对 Hedgehog 信号通路抑制剂维莫德吉治疗有反应。
Virchows Arch. 2018 Aug;473(2):241-246. doi: 10.1007/s00428-018-2397-y. Epub 2018 Jun 22.
9
MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD.微小RNA-130b通过CYLD抑制胃癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 Jun;37(6):7981-7. doi: 10.1007/s13277-015-4632-3. Epub 2015 Dec 28.
10
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.Sonic Hedgehog(Shh)信号与p50/Bcl3信号的相互作用驱动了基底细胞癌综合征中基底细胞癌的发病机制。
Oncotarget. 2015 Nov 3;6(34):36789-814. doi: 10.18632/oncotarget.5103.
Cancer Prev Res (Phila). 2011 Jun;4(6):851-9. doi: 10.1158/1940-6207.CAPR-10-0360. Epub 2011 Apr 8.
4
Hedgehog signaling in skin cancers. Hedgehog 信号通路与皮肤癌。
Cell Signal. 2011 Aug;23(8):1235-43. doi: 10.1016/j.cellsig.2011.03.002. Epub 2011 Mar 17.
5
CYLD: a deubiquitination enzyme with multiple roles in cancer.CYLD:一种具有多种癌症相关作用的去泛素化酶。
Future Oncol. 2011 Feb;7(2):285-97. doi: 10.2217/fon.10.187.
6
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.肿瘤抑制因子 Snf5 的缺失会导致 Hedgehog-Gli 信号通路的异常激活。
Nat Med. 2010 Dec;16(12):1429-33. doi: 10.1038/nm.2251. Epub 2010 Nov 14.
7
Emerging roles for the non-canonical IKKs in cancer.非经典 IKK 在癌症中的新兴作用。
Oncogene. 2011 Feb 10;30(6):631-41. doi: 10.1038/onc.2010.493. Epub 2010 Nov 1.
8
An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells.一个失活的 CYLD 突变通过赋予表皮癌细胞更强的增殖、存活和血管生成特性来促进皮肤肿瘤的进展。
Oncogene. 2010 Dec 16;29(50):6522-32. doi: 10.1038/onc.2010.378. Epub 2010 Sep 13.
9
SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors.PIAS1 通过 SUMOylation 调节 Hedgehog 依赖性 Gli 转录因子的活性。
PLoS One. 2010 Aug 11;5(8):e11996. doi: 10.1371/journal.pone.0011996.
10
Ubiquitin chain cleavage: CYLD at work.泛素链裂解:CYLD 在工作。
Trends Biochem Sci. 2010 Jul;35(7):392-9. doi: 10.1016/j.tibs.2010.02.007. Epub 2010 Mar 26.